Skip to main content

Tirzepatide News (Page 2)

FDA Approves Mounjaro (tirzepatide) Injection for the Treatment of Adults with Type 2 Diabetes

INDIANAPOLIS, May 13, 2022 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Weight Loss (Obesity / Overweight), Diabetes, Type 2

Related drug support groups

Mounjaro, Zepbound

Tirzepatide patient information at Drugs.com